Next-Generation Assays and Robotic Integration: Understanding the Technological Maturity of the High Throughput Screening Market
HTS platforms continue to advance as biotechnology organizations explore complex disease mechanisms requiring sophisticated detection methods. The shift toward cell-based assays, genomic-screening integration, and advanced fluorescence detection offers researchers deeper biological insights and more robust screening outcomes. Innovation in robotics allows high-speed dispensing, rapid plate...
0 Комментарии 0 Поделились 101 Просмотры 0 предпросмотр